Skip to Content

Environmental Health and Safety

Institutional Biosafety Committee (IBC)

The Institutional Biosafety Committee (IBC) provides local review and oversight for research involving recombinant or synthetic nucleic acids, and other potentially infectious or hazardous biological materials.

Biological Materials Requiring IBC Review and Approval

Research involving the following materials requires IBC review and approval of a protocol application prior to conducting experiments:

  • Recombinant or Synthetic Nucleic Acids
  • Human, Animal, or Plant Pathogens
  • Human-Derived Materials
  • HHS/USDA Select Agents or Biological Toxins

All protocols must be submitted using the IBC Protocol Management System

If you have any problems accessing or using the Topaz IBC Protocol Management System or need to add new protocol associates in Topaz, contact Sherika Smith at smiths69@mailbox.sc.edu.

You may contact USC's Biological Safety Officer if you would like to request a pre-review of your IBC protocol prior to full committee review or if you have any questions regarding the IBC protocol submission review or approval process.

Protocols must be submitted on or before the submission deadline for the scheduled meeting.

This schedule is subject to change since the IBC must verify a quorum attendance at each meeting.

Meeting Date Submission Deadline
February 20, 2019 (Wednesday) January 30, 2019 (Wednesday)
May 15, 2019 (Wednesday) April 24, 2019 (Wednesday)
August 21, 2019 (Wednesday) July 24, 2019 (Wednesday)
November 6, 2019 (Wednesday) October 14, 2019 (Monday)
  • Location: Benson Building, Conference Room 303
  • Start Time: 3 p.m.
  • The laboratory must have submitted a corrective action plan for all deficiencies identified during their most recent lab safety inspection
  • All personnel included on the protocol must be up-to-date on required Biosafety Training
  • All personnel included on the protocol must have completed any required occupational health services

The Institutional Biosafety Committee (IBC) provides local review and oversight for research involving recombinant or synthetic nucleic acids, and other potentially infectious or hazardous biological materials. The NIH Guidelines require the IBC to ensure that research conducted at or sponsored by the university is in compliance with the NIH Guidelines. This requirement is primarily met through the IBC’s review and approval of all research subject to the NIH Guidelines. Members of the IBC are responsible for providing the collective experience and expertise in research involving these materials and the capability to assess the safety of research protocols and to identify any potential risk to workers, other persons, or the environment.

The IBC Charter includes additional information about the committee’s policies and procedures:

USC Institutional Biosafety Committee (IBC) Charter [pdf]

Public Notice on IBC Meetings and Minutes [pdf]

 


Challenge the conventional. Create the exceptional. No Limits.

©